The Klinikum Großhadern of the Ludwig Maximilian University of Munich in the Großhadern district of Hadern is the largest hospital complex in Munich, owing to its affiliated institutions and 1,940 beds.

There are 1,940 beds in University Hospital, LMU Munich.

During the past decade, University Hospital, LMU Munich conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 8 clinical trials were completed, i.e. on average, 34.8% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 3 clinical trials were completed. i.e. 27.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital, LMU Munich" #1 sponsor was "LMU Klinikum" with 5 trials, followed by "Pfizer" with 4 trials sponsored, "Incyte Corporation" with 3 trials sponsored, "Ludwig-Maximilians - University of Munich" with 3 trials sponsored and "Crinetics Pharmaceuticals Inc." with 3 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital, LMU Munich" #1 collaborator was "Medivation, Inc." with 2 trials as a collaborator, "Medtronic" with 2 trials as a collaborator, "Algora" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital, LMU Munich" are "Breast Neoplasms" (3 trials), "Acromegaly" (2 trials), "BRCA 1 Gene Mutation" (2 trials), "BRCA 2 Gene Mutation" (2 trials) and "Ulcerative Colitis" (2 trials). Many other conditions were trialed in "University Hospital, LMU Munich" in a lesser frequency.

Most popular intervention types in "University Hospital, LMU Munich" are "Drug" (17 trials), "Device" (7 trials), "Other" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Paltusotine" (2 trials), "Pemigatinib" (2 trials), "talazoparib" (2 trials) and "ACTIVA® PC neurostimulator (Model 37601)" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital, LMU Munich" are 32 trials for "All" genders.

Currently, there are NaN active trials in "University Hospital, LMU Munich". undefined are not yet recruiting, 8 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in University Hospital, LMU Munich, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital, LMU Munich, 3 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".

University Hospital, LMU Munich has several departments that took part in Clinical trials: "Department of Radiation Oncology, University Hospital, LMU Munich" - 8 trials, "Friedrich-Baur-Institute, Dep. of Neurology Klinikum der Universitaet Muenchen Munich, Germany" - 7 trials, "Department of Anaesthesiology of the University Hospital of Munich" - 5 trials, "Department of Neurosurgery" - 5 trials, "Klinik für Neurologie, Ludwig-Maximilliams-Universität, Klinikum Grosshadern" - 4 trials, "University Hospital Munich - Dep. of Internal Medicine" - 4 trials, "Clinical Research unit, Dept. of Internal Medicine II - Großhadern, University of Munich" - 4 trials, "Dr. von Hauner Children´s Hospital" - 3 trials, "Department of Trauma Surgery, Medical University of Munich" - 3 trials, "Dept. of Ophthalmology, LMU Munich" - 2 trials, "Neurologische Klinik- klinikum Grosshadern" - 2 trials, "Med. Dept. 2, University Munich" - 2 trials, "Prof. Claus Belka" - 2 trials, "Klinikum der Universität München, Campus Innenstadt; Hämostaseologische Ambulanz/Hämophiliezentrum" - 2 trials, "Ludwig-Maximilians-University Munich, Dept. of Dermatology" - 2 trials, "Div. Metabolic and Nutritional Medicine Dr. von Hauner Children's Hospital Univ. of Munich Medical Centre" - 2 trials, "Klinikum der LMU, Dr. von Haunersches Kinderspital, Pädiatrische Hämatologie / Onkologie" - 2 trials, "Medizinische Klinik und Poliklinik I der Ludwig-Maximilians-Universität München / Klinikum Großhadern, Schwerpunkt Pneumologie" - 2 trials, "Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich" - 2 trials, "Department of Ear Nose Throat" - 2 trials, "LMU Clinic of University of Munich, Medical Clinic and Polyclinic IV" - 2 trials, "Ludwig Maximilian University, University Hosipital, Department of Orthopedics, Physical Medicine and Rehabilitation" - 2 trials